Imagenebio, INC. (IMA) SEC Filings — 2025
22 SEC filings for Imagenebio, INC. (IMA) in 2025.
Filings
- ImageneBio, Inc. Reports Board and Executive Compensation Changes — 8-K · Dec 18, 2025
- ImageneBio, Inc. Files 8-K — 8-K · Nov 19, 2025
- ImageneBio's Losses Mount Amid Soaring R&D, Cash Position Strengthens Post-PIPE — 10-Q · Nov 12, 2025
- Imagenebio, INC. 8-K Filing — 8-K · Nov 5, 2025
- ImageneBio Reports Material Agreement Entry & Termination — 8-K · Oct 29, 2025
- ImageneBio Reports Director/Officer Changes & Compensation Updates — 8-K · Oct 22, 2025
- ImageneBio, Inc. Reports Leadership Changes and Compensation Updates — 8-K · Oct 10, 2025
- ImageneBio Debuts on Nasdaq, Eyes $257B Immunology Market with Lead Asset IMG-007 — S-1 · Sep 8, 2025
- ImageneBio Files 8-K/A Amendment on Asset Acquisition — 8-K/A · Aug 12, 2025
- ImageneBio Changes Certifying Accountant to 03 Life Sciences — 8-K · Aug 5, 2025
- ImageneBio Appoints Dr. David R. Walt to Board — 8-K · Aug 1, 2025
- ImageneBio Reports Multiple Material Events — 8-K · Jul 29, 2025
- Imigenebio, Inc. Changes Name from Ikena Oncology, Inc. — 8-K · Jul 25, 2025
- Ikena Oncology Files 8-K Report — 8-K · Jul 24, 2025
- Ikena Narrows Losses Amid Inmagene Merger Ahead of Immunology Pivot — 10-Q · Jul 24, 2025
- Ikena Oncology Files 8-K: Other Events Reported — 8-K · Jul 22, 2025
- Ikena Oncology Reports Director Changes and Executive Compensation Adjustments — 8-K · Jul 16, 2025
- Ikena Oncology Files 8-K on Officer/Director Changes — 8-K · Jul 15, 2025
- Ikena Oncology Files 8-K Report — 8-K · Jul 11, 2025
- Ikena Oncology Files 8-K Report — 8-K · Jul 1, 2025
- Ikena Oncology Files Q1 2025 10-Q, Details Merger & Loan — 10-Q · May 8, 2025
- Ikena Oncology Files 2024 10-K, Cites Pionyr Acquisition — 10-K · Mar 6, 2025